Alamar Biosciences, Inc.

Alamar Biosciences, Inc. (ALMR) files with the SEC as an information technology company. Its most recent balance sheet puts total assets at $186M, against $130M of liabilities and -$178M of equity, as at 2026-03-31. That balance sheet grew 33.2% against 2025-12-31, when total assets were $140M. Liabilities account for 69.5% of the balance sheet and equity -95.5%. The largest single line on the asset side is Cash at $65M, 34.6% of total assets, followed by Inventory at $40M. Its largest single liability is Accounts payable at $6M, 3.0% of the balance sheet. By total assets it is the 553rd largest of the 964 information technology companies covered here. Equity is negative, so the claims against this company exceed what it owns on the filed figures. That is a real shape, not an error, and it is drawn below the baseline rather than hidden. The figures come from a filing filed on 2026-05-08. Some line items this filer reports are not broken out separately here; the totals are complete and the difference is shown as a remainder rather than distributed across the lines that are named. The filing presents redeemable instruments between liabilities and equity, so it reconciles once that mezzanine block is included — every figure as filed. Every figure above is as filed. Nothing is estimated, smoothed or restated, and where the filing and the identity disagree the disagreement is shown rather than closed.